Molecular mechanisms of mTOR-mediated translational control

XM Ma, J Blenis - Nature reviews Molecular cell biology, 2009 - nature.com
The process of translation requires substantial cellular resources. Cells have therefore
evolved complex mechanisms to control overall protein synthesis as well as the translation …

Defining the role of mTOR in cancer

DA Guertin, DM Sabatini - Cancer cell, 2007 - cell.com
The mammalian target of rapamycin (mTOR) has emerged as a critical effector in cell-
signaling pathways commonly deregulated in human cancers. This has led to the prediction …

mTOR and cancer: insights into a complex relationship

DM Sabatini - Nature Reviews Cancer, 2006 - nature.com
Abstract mTOR (mammalian target of rapamycin) has come a long way since its humble
beginnings as a kinase of unknown function. As part of the mTORC1 and mTORC2 …

Rapamycin protects against rotenone-induced apoptosis through autophagy induction

T Pan, P Rawal, Y Wu, W Xie, J Jankovic, W Le - Neuroscience, 2009 - Elsevier
Ubiquitin proteasome system (UPS) and autophagy lysosome pathway (ALP) are the two
most important routes for degradation of aggregated/misfolded proteins. Additionally, ALP is …

Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK

R Nussinov, BR Yavuz, MK Arici, HC Demirel… - Biophysical …, 2023 - Springer
Neurodevelopmental disorders (NDDs) and cancer share proteins, pathways, and
mutations. Their clinical symptoms are different. However, individuals with NDDs have …

Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular …

PC Tapia - Medical hypotheses, 2006 - Elsevier
The precise mechanistic sequence producing the beneficial effects on health and lifespan
seen with interventions as diverse as caloric restriction, intermittent fasting, exercise, and …

Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells

D Cretella, C Fumarola, M Bonelli, R Alfieri… - Scientific reports, 2019 - nature.com
Abstract Triple Negative Breast Cancer (TNBC) is a challenging disease due to the lack of
druggable targets; therefore, chemotherapy remains the standard of care and the …

Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement

T Pan, S Kondo, W Zhu, W Xie, J Jankovic, W Le - Neurobiology of disease, 2008 - Elsevier
The ubiquitin–proteasome system (UPS) and the autophagy-lysosomal pathway (ALP) are
the two most important cellular mechanisms for protein degradation. To investigate the role …

The mTOR pathway: a new target in cancer therapy

L Ciuffreda, C Di Sanza, UC Incani… - Current cancer drug …, 2010 - ingentaconnect.com
Mammalian target of rapamycin (mTOR) is a key protein kinase controlling signal
transduction from various growth factors and upstream proteins to the level of mRNA …

[HTML][HTML] Combined inhibition of CDK4/6 and PI3K/AKT/mTOR pathways induces a synergistic anti-tumor effect in malignant pleural mesothelioma cells

MA Bonelli, G Digiacomo, C Fumarola, R Alfieri… - Neoplasia, 2017 - Elsevier
Malignant pleural mesothelioma (MPM) is a progressive malignancy associated to the
exposure of asbestos fibers. The most frequently inactivated tumor suppressor gene in MPM …